News-Medical.Net on MSN4h
New trial shows oral semaglutide reduces cardiovascular events in diabetes patients
Both the injectable and oral forms of semaglutide, a glucagon-like peptide-1 receptor agonist, have gained recent attention ...
I Used to Be My Boyfriend’s Biggest, Most Secret Turn-On. Now I’m the Opposite.
How do I handle finding out that I was a fetish for my boyfriend, and that now I’m not anymore? I’m so uncomfortable thinking ...
News Medical on MSN19h
Reduced-dose apixaban proves effective in preventing blood clot recurrence in cancer patients
Patients with active cancer who developed a blood clot, or venous thromboembolism (VTE), and were treated with blood-thinning medication for at least six months, followed by an additional 12 months of ...